We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guillain-Barré syndrome is a rare neurological condition which can occur following Zika virus infection.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
This factsheet is for tied pub tenants who want information about trigger events
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Report highlighting the lessons identified by the trial areas which is intended to be used by agencies for their own community trigger procedures
Comply with good pharmacovigilance practice and prepare for an inspection.
Research to understand how trigger prompts affect customer experiences of completing their Self Assessment tax return.
The medicines used to treat vitamin B12 deficiency (hydroxocobalamin, cyanocobalamin) contain cobalt. There are case reports in the literature describing cobalt sensitivity-type reactions in patients being treated for vitamin B12 deficiency.
Globally, there has been a very small number of reports of new-onset or aggravation of pre-existing myasthenia gravis with atorvastatin, pravastatin, lovastatin, fluvastatin, simvastatin, rosuvastatin and pitavastatin (single-ingredient and fixed-dose combination products). Advise patients taking statins to be alert to...
Urgent public health message on coronavirus (COVID-19) hospitalised cases who have travelled from China in the preceding 14 days.
An independent piece of research on ‘trigger points’ for switching suppliers in regulated markets whether in banking, energy or telecoms.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.